Compare WRBY & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WRBY | PRGO |
|---|---|---|
| Founded | 2010 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2021 | 1991 |
| Metric | WRBY | PRGO |
|---|---|---|
| Price | $27.05 | $13.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 4 |
| Target Price | ★ $25.43 | $22.00 |
| AVG Volume (30 Days) | ★ 5.5M | 3.7M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.91% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $850,580,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $15.47 | N/A |
| Revenue Next Year | $12.84 | N/A |
| P/E Ratio | $10,724.35 | ★ N/A |
| Revenue Growth | ★ 14.55 | N/A |
| 52 Week Low | $13.63 | $12.17 |
| 52 Week High | $31.00 | $30.93 |
| Indicator | WRBY | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 65.57 | 39.47 |
| Support Level | $25.78 | $12.74 |
| Resistance Level | $31.00 | $13.63 |
| Average True Range (ATR) | 1.94 | 0.44 |
| MACD | 0.83 | 0.25 |
| Stochastic Oscillator | 67.43 | 47.29 |
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.